UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Impact of new physics on B + L violation at colliders

Journal of physics. Conference series, 2020-08, Vol.1586 (1), p.12044

2020

Volltextzugriff (PDF)

Mirtazapine versus amitriptyline in the long-term treatment of depression: a double-blind placebo-controlled study

International clinical psychopharmacology, 1998-03, Vol.13 (2), p.63-74

1998

Volltextzugriff (PDF)

Potential of CMS as a high-energy neutrino scattering experiment

Physical review. D, 2021-12, Vol.104 (11), Article 113005

2021

Volltextzugriff (PDF)

Effectiveness and safety of edoxaban in atrial fibrillation patients from the ETNA-AF global registry

European heart journal, 2021-10, Vol.42 (Supplement_1)

2021

Volltextzugriff (PDF)

Edoxaban for stroke prevention in atrial fibrillation in routine clinical care: 1-year follow-up of the prospective observational ETNA-AF-Europe study

European heart journal. Cardiovascular pharmacotherapy, 2021-04, Vol.7 (Supplement_FI1), p.f30-f39

2021

Volltextzugriff (PDF)

Recommended and non-recommended edoxaban dosing in patients with atrial fibrillation (AF): one-year clinical events from the Global ETNA-AF non-interventional study (NIS)

European heart journal, 2020-11, Vol.41 (Supplement_2)

2020

Volltextzugriff (PDF)

Edoxaban treatment of elderly patients with atrial fibrillation in routine clinical practice: 1-year results of the non-interventional Global ETNA-AF program

European heart journal, 2020-11, Vol.41 (Supplement_2)

2020

Volltextzugriff (PDF)

Temporal trend of clinical events in patients with atrial fibrillation on edoxaban therapy: results from the non-interventional global ETNA-AF program

European heart journal, 2021-10, Vol.42 (Supplement_1)

2021

Volltextzugriff (PDF)

Edoxaban treatment in real-world practice is highly concordant with ESC atrial fibrillation guidelines: results from the non-interventional global ETNA-AF program

European heart journal, 2021-10, Vol.42 (Supplement_1)

2021

Volltextzugriff (PDF)

PP.21.16: META-ANALYSIS OF OLMESARTAN-BASED SINGLE PILL COMBINATION VERSUS MONOTHERAPY FOR REDUCING BLOOD PRESSURE

Journal of hypertension, 2015-06, Vol.33 (Supplement 1), p.e323

2015

Volltextzugriff (PDF)

Baseline characteristics of major depressive disorder patients in clinical trials in Europe and United States: is there a transatlantic difference?

Journal of psychiatric research, 2001-03, Vol.35 (2), p.71-81

2001

Volltextzugriff (PDF)

P4785Clinical characteristics and 1-year outcomes in atrial fibrillation patients with or without history of intracranial haemorrhage treated with edoxaban: snapshot analysis of the Global ETNA-AF program

European heart journal, 2019-10, Vol.40 (Supplement_1)

2019

Volltextzugriff (PDF)

P4788One-year outcomes of elderly patients with atrial fibrillation: snapshot data from the global noninterventional program on edoxaban treatment in routine clinical practice in atrial fibrillation

European heart journal, 2019-10, Vol.40 (Supplement_1)

2019

Volltextzugriff (PDF)

Low bleeding and stroke rates with minor age-dependent increase confirm the safety and effectiveness of edoxaban in patients with atrial fibrillation across age groups: Two-year results from ETNA-AF

Europace (London, England), 2021-05, Vol.23 (Supplement_3)

2021

Volltextzugriff (PDF)

Annualized clinical event rates during two-year follow-up are low in 27,617 atrial fibrillation patients on edoxaban: results from the global noninterventional ETNA-AF program

Europace (London, England), 2021-05, Vol.23 (Supplement_3)

2021

Volltextzugriff (PDF)

PP.07.16: META-ANALYSIS OF BLOOD PRESSURE REDUCTIONS WITH OLMESARTAN MEDOXOMIL IN CLINICAL COMPARISONS WITH ACTIVE CONTROLS IN PATIENTS WITH HYPERTENSION

Journal of hypertension, 2015-06, Vol.33 (Supplement 1), p.e194

2015

Volltextzugriff (PDF)

PP.07.01: META-ANALYSIS OF OLMESARTAN MEDOXOMIL MONOTHERAPY IN REDUCING BLOOD PRESSURE IN ELDERLY PATIENTS WITH HYPERTENSION

Journal of hypertension, 2015-06, Vol.33 (Supplement 1), p.e190

2015

Volltextzugriff (PDF)

A prospective, randomized study to assess the tolerance and efficacy of intramuscular and subcutaneous administration of recombinant follicle-stimulating hormone (Puregon)

Fertility and sterility, 1997-02, Vol.67 (2), p.278-283

1997

Volltextzugriff (PDF)

Comparing the onset of action of antidepressants: Comparison of different criteria applied to the same data set

European psychiatry, 1998-05, Vol.13 (3), p.124-127

1998

Volltextzugriff (PDF)

Treatment Satisfaction In Patients With Atrial Fibrillation On New Oral Anticoagulants As Assessed With Pact-Q2 At Baseline And 12-Month Follow-Up: Prefer In Af Registry

Value in health, 2014-11, Vol.17 (7), p.A497-A497

2014

Volltextzugriff (PDF)

Health State In Patients With Atrial Fibrillation On New Oral Anticoagulants As Assessed With The New Eq-5d-5l Questionnaire At Baseline And 12-Month Follow-Up: Prefer In Af Registry

Value in health, 2014-11, Vol.17 (7), p.A493-A493

2014

Volltextzugriff (PDF)

Discontinuation And Hospitalisation Rates In Patients With Atrial Fibrillation: Follow-Up Results Of The Prefer In Af Registry

Value in health, 2014-11, Vol.17 (7), p.A473-A473

2014

Volltextzugriff (PDF)

Meta-analysis of randomized, double-blind, placebo-controlled, efficacy and safety studies of mirtazapine versus amitriptyline in major depression

Acta psychiatrica Scandinavica. Supplementum, 1997, Vol.391, p.22

1997

Volltextzugriff (PDF)

Leitlinien zur Durchführung von Anwendungsbeobachtungen (AWB) in der Psychopharmakotherapie

Nervenarzt, 1994, Vol.65 (9), p.638-644

1994

Volltextzugriff (PDF)

Selecting investigators for a placebo controlled clinical trial: The most critical decision point?

European psychiatry, 1997, Vol.12 (S3), p.261s-262s

1997

Volltextzugriff (PDF)

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(61)
Bücher
(1)

Sprache

Englisch
(51)
Deutsch
(11)

Erscheinungsjahr

n.n

Thema

Humans
(16)
Science & Technology
(16)
Female
(14)
Life Sciences & Biomedicine
(14)
Male
(13)
Middle Aged
(11)
Adult
(9)
Psychiatry
(9)
Biological And Medical Sciences
(8)
Medical Sciences
(8)
Pharmacology. Drug Treatments
(6)
Psychology. Psychoanalysis. Psychiatry
(6)
Aged
(5)
Internal Medicine
(5)
Neuropharmacology
(5)
Psychoanaleptics: Cns Stimulant, Antidepressant Agent, Nootropic Agent, Mood Stabilizer...,
(5)
Psychopharmacology
(5)
Adolescent
(4)
Depressive Disorder - Drug Therapy
(4)
Treatment Outcome
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Impact of new physics on B + L violation at colliders

Mirtazapine versus amitriptyline in the long-term treatment of depression: a double-blind placebo-controlled study

Potential of CMS as a high-energy neutrino scattering experiment

Effectiveness and safety of edoxaban in atrial fibrillation patients from the ETNA-AF global registry

Edoxaban for stroke prevention in atrial fibrillation in routine clinical care: 1-year follow-up of the prospective observational ETNA-AF-Europe study

Recommended and non-recommended edoxaban dosing in patients with atrial fibrillation (AF): one-year clinical events from the Global ETNA-AF non-interventional study (NIS)

Edoxaban treatment of elderly patients with atrial fibrillation in routine clinical practice: 1-year results of the non-interventional Global ETNA-AF program

Temporal trend of clinical events in patients with atrial fibrillation on edoxaban therapy: results from the non-interventional global ETNA-AF program

Edoxaban treatment in real-world practice is highly concordant with ESC atrial fibrillation guidelines: results from the non-interventional global ETNA-AF program

PP.21.16: META-ANALYSIS OF OLMESARTAN-BASED SINGLE PILL COMBINATION VERSUS MONOTHERAPY FOR REDUCING BLOOD PRESSURE

Baseline characteristics of major depressive disorder patients in clinical trials in Europe and United States: is there a transatlantic difference?

P4785Clinical characteristics and 1-year outcomes in atrial fibrillation patients with or without history of intracranial haemorrhage treated with edoxaban: snapshot analysis of the Global ETNA-AF program

P4788One-year outcomes of elderly patients with atrial fibrillation: snapshot data from the global noninterventional program on edoxaban treatment in routine clinical practice in atrial fibrillation

Low bleeding and stroke rates with minor age-dependent increase confirm the safety and effectiveness of edoxaban in patients with atrial fibrillation across age groups: Two-year results from ETNA-AF

Annualized clinical event rates during two-year follow-up are low in 27,617 atrial fibrillation patients on edoxaban: results from the global noninterventional ETNA-AF program

PP.07.16: META-ANALYSIS OF BLOOD PRESSURE REDUCTIONS WITH OLMESARTAN MEDOXOMIL IN CLINICAL COMPARISONS WITH ACTIVE CONTROLS IN PATIENTS WITH HYPERTENSION

PP.07.01: META-ANALYSIS OF OLMESARTAN MEDOXOMIL MONOTHERAPY IN REDUCING BLOOD PRESSURE IN ELDERLY PATIENTS WITH HYPERTENSION

A prospective, randomized study to assess the tolerance and efficacy of intramuscular and subcutaneous administration of recombinant follicle-stimulating hormone (Puregon)

Comparing the onset of action of antidepressants: Comparison of different criteria applied to the same data set

Treatment Satisfaction In Patients With Atrial Fibrillation On New Oral Anticoagulants As Assessed With Pact-Q2 At Baseline And 12-Month Follow-Up: Prefer In Af Registry

Health State In Patients With Atrial Fibrillation On New Oral Anticoagulants As Assessed With The New Eq-5d-5l Questionnaire At Baseline And 12-Month Follow-Up: Prefer In Af Registry

Discontinuation And Hospitalisation Rates In Patients With Atrial Fibrillation: Follow-Up Results Of The Prefer In Af Registry

Meta-analysis of randomized, double-blind, placebo-controlled, efficacy and safety studies of mirtazapine versus amitriptyline in major depression

Leitlinien zur Durchführung von Anwendungsbeobachtungen (AWB) in der Psychopharmakotherapie

Selecting investigators for a placebo controlled clinical trial: The most critical decision point?

Suchergebnisse filtern